Mesoblast (MESO) Other Non-Current Assets (2015 - 2025)
Mesoblast's (MESO) quarterly Other Non-Current Assets came in at $1.2 million in Q4 2025, down 10.43% year-on-year from $1.3 million in Q4 2024, and down 7.87% quarter-over-quarter from $1.3 million in Q2 2025.
Mesoblast (MESO) Other Non-Current Assets (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $1.2 million for Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $1.2 million, down 10.43% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.2 million (down 10.43% YoY), and the FY2025 annual result was $1.3 million, down 38.34% from the prior year.
- Other Non-Current Assets came in at $1.2 million for Q4 2025 at Mesoblast, down from $1.3 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.2 million in Q1 2021 to a low of $1.2 million in Q4 2025.
- The 5-year median for Other Non-Current Assets is $2.0 million (2021), against an average of $2.0 million.
- Across the five-year window, Other Non-Current Assets tumbled 47.93% in 2021 and advanced 21.03% in 2023, its largest moves.
- Mesoblast's Other Non-Current Assets stood at $2.0 million in 2021, then decreased by 1.74% to $1.9 million in 2022, then grew by 16.6% to $2.2 million in 2023, then sank by 40.52% to $1.3 million in 2024, then fell by 10.43% to $1.2 million in 2025.
- The last three Other Non-Current Assets figures came in at $1.2 million (Q4 2025), $1.3 million (Q2 2025), and $1.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Jun 30, 2024 | 2.10 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Jun 30, 2023 | 2.33 Mn |
| Mar 31, 2023 | 2.39 Mn |
| Dec 31, 2022 | 1.92 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 1.93 Mn |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 1.96 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 1.72 Mn |
| Mar 31, 2021 | 3.20 Mn |
| Dec 31, 2020 | 3.21 Mn |
| Sep 30, 2020 | 3.33 Mn |
| Jun 30, 2020 | 3.31 Mn |
| Mar 31, 2020 | 3.24 Mn |
| Dec 31, 2019 | 3.32 Mn |